Findings

What do systematic reviews say?

4,315 questions · 23,557 findings · 2,311 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 4,183 · 17.8%GRADE not reported 3,930 · 16.7%Very low 5,371 · 22.8%Low 5,787 · 24.6%Moderate 3,320 · 14.1%High 966 · 4.1%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Colchicine single dose vs divided dose

Prevention of AA amyloidosis · children with familial Mediterranean fever

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for reducing inflammation in familial Mediterranean fever 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Colchicine (oral) vs placebo

Prevention of AA amyloidosis · people with familial Mediterranean fever

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for reducing inflammation in familial Mediterranean fever 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Remifentanil vs diazepam

Maternal respiratory rate (Maternal respiratory depression as defined by trial authors or measured using intraoperative maternal arterial oxygen saturation and maternal respiratory rate) · health problem or population

1 finding from 1 review

Perioperative pharmacological interventions for fetal immobilisation during fetal surgery and invasive procedures 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 50 participants
Low

Summary of findings: unconditional cash transfer vs no unconditional cash transfer: primary outcomes

Has used any health service in previous 1 to 12 months · children (0 to 17 years) and adults (≥ 18 years) or households

Summary of findings: unconditional cash transfer showed no clear difference in has used any health service in previous 1 to 12 months compared with no unconditional cash transfer: primary outcomes (low certainty).

1 finding from 1 review

Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health… 2022 · Cochrane Headline outcomes only
RR 1.04 [1, 1.09]
4972 participants
Low

Summary of findings: unconditional cash transfer vs conditional cash transfers: primary outcomes

Has used any health service in previous 1 to 12 months · children (0 to 17 years) and adults (≥ 18 years) or households

1 finding from 1 review

Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health… 2022 · Cochrane Headline outcomes only
no estimate extracted
2559 participants
Very low

Summary of findings: unconditional cash transfer vs conditional cash transfers: primary outcomes

Has had any illness in previous 2 weeks to 3 months · children (0 to 17 years) and adults (≥ 18 years) or households

It is very uncertain whether summary of findings: unconditional cash transfers changes has had any illness in previous 2 weeks to 3 months compared with conditional cash transfers: primary outcomes (very low certainty).

1 finding from 1 review

Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health… 2022 · Cochrane Headline outcomes only
RR 1.11 [0.95, 1.25]
3896 participants
Very low

Summary of findings: unconditional cash transfer vs conditional cash transfers: primary outcomes

Dietary diversity · children (0 to 17 years) and adults (≥ 18 years) or households

1 finding from 1 review

Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health… 2022 · Cochrane Headline outcomes only
no estimate extracted
3896 participants
Very low

Summary of findings: unconditional cash transfer vs conditional cash transfers: primary outcomes

Level of depression · children (0 to 17 years) and adults (≥ 18 years) or households

The review found no eligible studies for this question.

1 finding from 1 review

Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health… 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: unconditional cash transfer vs no unconditional cash transfer: primary outcomes

Has had any illness in previous 2 weeks to 3 months · children (0 to 17 years) and adults (≥ 18 years) or households

Summary of findings: unconditional cash transfer probably leads to lower has had any illness in previous 2 weeks to 3 months compared with no unconditional cash transfer: primary outcomes (moderate certainty).

1 finding from 1 review

Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health… 2022 · Cochrane Headline outcomes only
RR 0.79 [0.67, 0.92]
9367 participants
Moderate

Summary of findings: unconditional cash transfer vs no unconditional cash transfer: primary outcomes

Has been food secure in previous month · children (0 to 17 years) and adults (≥ 18 years) or households

Summary of findings: unconditional cash transfer may leads to higher has been food secure in previous month compared with no unconditional cash transfer: primary outcomes (low certainty).

1 finding from 1 review

Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health… 2022 · Cochrane Headline outcomes only
RR 1.25 [1.09, 1.45]
2687 participants
Low

Summary of findings: unconditional cash transfer vs no unconditional cash transfer: primary outcomes

Dietary diversity · children (0 to 17 years) and adults (≥ 18 years) or households

1 finding from 1 review

Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health… 2022 · Cochrane Headline outcomes only
no estimate extracted
9347 participants
Low

Summary of findings: unconditional cash transfer vs no unconditional cash transfer: primary outcomes

Level of depression · children (0 to 17 years) and adults (≥ 18 years) or households

1 finding from 1 review

Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health… 2022 · Cochrane Headline outcomes only
no estimate extracted
9497 participants
Very low

Summary of findings: unconditional cash transfer vs no unconditional cash transfer: primary outcomes

Owned livestock in previous year · children (0 to 17 years) and adults (≥ 18 years) or households

1 finding from 1 review

Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health… 2022 · Cochrane Headline outcomes only
no estimate extracted
7324 participants
Very low

Binocular iPad treatment vs occlusion therapy

Participant adherence to intervention · 5‐ to 8‐year‐old children with amblyopia

1 finding from 1 review

Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 63 participants
Moderate

Laigle‐Donadey 2019: dexamfetamine sulfate vs placebo

Depressive symptoms · people with a primary brain tumour

1 finding from 1 review

Interventions for the management of fatigue in adults with a primary brain tumour 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Very low

Autologous myeloablative selective HSCT vs cyclophosphamide

Functional ability · people with systemic sclerosis

Autologous myeloablative selective HSCT may leads to higher functional ability – HAQ‐DIb Scale 0–3 with 0 representing no/mild… compared with cyclophosphamide (low certainty).

1 finding from 1 review

Stem cell transplantation for systemic sclerosis 2022 · Cochrane Headline outcomes only
RR 3.43 [1.54, 7.62]
1 study · 75 participants
Low

Autologous myeloablative selective HSCT vs cyclophosphamide

FVC · people with systemic sclerosis

Autologous myeloablative selective HSCT showed no clear difference in interstitial lung disease – FVC (% predicted) A lower percentage… compared with cyclophosphamide (moderate certainty).

1 finding from 1 review

Stem cell transplantation for systemic sclerosis 2022 · Cochrane Headline outcomes only
RR 1.63 [0.75, 3.51]
1 study · 75 participants
Moderate

Autologous non‐myeloablative non‐selective HSCT vs cyclophosphamide

Functional ability · people with systemic sclerosis

The review found no eligible studies for this question.

1 finding from 1 review

Stem cell transplantation for systemic sclerosis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Autologous non‐myeloablative non‐selective HSCT vs cyclophosphamide

Interstitial lung disease – FVC % predicted A lower percentage represents worse lung disease. The study incorporated a ≥ 15% chance · people with systemic sclerosis

1 finding from 1 review

Stem cell transplantation for systemic sclerosis 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 19 participants
Low

Autologous non‐myeloablative selective HSCT vs cyclophosphamide

Functional ability · people with systemic sclerosis

1 finding from 1 review

Stem cell transplantation for systemic sclerosis 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 131 participants
Low